Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
Journal
American heart journal
Journal Volume
160
Journal Issue
5
Pages
785
Date Issued
2010-11-01
Author(s)
Baigent C.
Landray M.
Reith C.
Dasgupta T.
Emberson J.
Herrington W.
Lewis D.
Mafham M.
Collins R.
Bray C.
Chen Y.
Baxter A.
Young A.
Hill M.
Knott C.
Cass A.
Abstract
Lowering low-density lipoprotein (LDL) cholesterol with statin therapy has been shown to reduce the incidence of atherosclerotic events in many types of patient, but it remains uncertain whether it is of net benefit among people with chronic kidney disease (CKD).
Subjects
REQUIRING PROLONGED OBSERVATION
UNITED-KINGDOM HEART
CARDIOVASCULAR OUTCOMES
simvastatin
efficacy
EZETIMIBE
design
statins
safety
SDGs
Publisher
MOSBY-ELSEVIER
Type
journal article